WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Structure Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GPCR annual revenue was $0.0, with N/A growth year-over-year.

GPCR revenue history

Current Revenue
$0.0
Current Earnings
-$122.5M
Current Profit Margin
0%

Be the first to know when GPCR announces revenue.

GPCR Revenue History By Year

GPCR Yearly RevenueGPCR RevenueGPCR ChangeGPCR Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Structure Therapeutics Revenue FAQ

What was GPCR's revenue last quarter?

Structure Therapeutics (NASDAQ: GPCR) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Structure Therapeutics's revenue was $0.00.

What was Structure Therapeutics's revenue in 2024?

Structure Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Structure Therapeutics make in a day?

Based on Structure Therapeutics annual revenue for the past four years, GPCR makes an average of $0.00 per day.

What was Structure Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Structure Therapeutics's revenue has grown null year over year. Structure Therapeutics's revenue in the past year totaled $0.00.

How much does Structure Therapeutics make in a year?

Structure Therapeutics's revenue by year for the past four years is:
  • Structure Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Structure Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Structure Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Structure Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.